Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-2,847
Closed -$204K 958
2017
Q3
$204K Buy
+2,847
New +$198K ﹤0.01% 838
2017
Q2
Sell
-13,363
Closed -$902K 888
2017
Q1
$902K Buy
13,363
+6,681
+100% +$445K 0.01% 792
2016
Q4
$413K Buy
+6,682
New +$395K 0.01% 684
2016
Q2
Sell
-9,064
Closed -$446K 920
2016
Q1
$446K Buy
+9,064
New +$386K 0.01% 710
2014
Q3
Sell
-1,685
Closed -$216K 957
2014
Q2
$216K Hold
1,685
0.01% 916
2014
Q1
$207K Buy
+1,685
New +$194K 0.01% 882
2013
Q4
Sell
-3,428
Closed -$333K 934
2013
Q3
$333K Buy
+3,428
New +$316K 0.01% 729

Other funds holding ENOV

Barings's ENOV Position: Q4 2017 in Review

Barings sold out of Enovis (ENOV) in Q4 2017, closing a stake of 2,847 shares — an estimated $204K sold.

Barings first reported a position in ENOV in Q3 2013 and held it in 7 quarters. The position peaked at $902K in Q1 2017. 210 funds tracked by Wall St. Rank hold ENOV as of Q4 2017.

  • Barings reported no remaining Enovis position as of Q4 2017 after selling out during the quarter.
  • Barings sold 2,847 Enovis shares in Q4 2017, an estimated $204K.
  • Barings first reported a position in Enovis in Q3 2013 and held it in 7 quarters.
  • Barings's Enovis position peaked at $902K in Q1 2017.
  • 210 funds tracked by Wall St. Rank held Enovis as of Q4 2017.

Based on Barings's 13F filing for Q4 2017, filed 8 Feb 2018.